Jianxin Li Selected Research

2- (3,4- dimethoxybenzyl)- 7- (1- (1- hydroxyethyl)- 4- phenylbutyl)- 5- methylimidazo(5,1- f)(1,2,4)triazin- 4 (3H)-one

2/2015	Inhibition of phosphodiesterase 2 reverses impaired cognition and neuronal remodeling caused by chronic stress.
7/2014	Protective effects of phosphodiesterase 2 inhibitor on depression- and anxiety-like behaviors: involvement of antioxidant and anti-apoptotic mechanisms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jianxin Li Research Topics

Disease

19	Neoplasms (Cancer) 03/2024 - 11/2005
18	Cardiovascular Diseases (Cardiovascular Disease) 05/2024 - 10/2012
14	Hypertension (High Blood Pressure) 01/2023 - 08/2012
8	Stroke (Strokes) 05/2024 - 01/2019
6	Obesity 10/2023 - 05/2009
5	Coronary Artery Disease (Coronary Atherosclerosis) 05/2024 - 01/2020
5	Inflammation (Inflammations) 01/2018 - 01/2012
4	Genetic Risk Score 11/2023 - 02/2016
4	Body Weight (Weight, Body) 10/2023 - 03/2013
4	Pre-Eclampsia (Preeclampsia) 08/2020 - 11/2016
3	Ischemic Stroke 05/2024 - 12/2019
3	Hemorrhagic Stroke 05/2024 - 12/2019
3	Diabetes Mellitus 05/2024 - 04/2010
3	Stomach Neoplasms (Stomach Cancer) 01/2024 - 01/2020
3	Osteoarthritis 10/2023 - 05/2018
3	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 01/2021
3	Atherosclerosis 01/2023 - 07/2009
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 10/2015
3	Thrombosis (Thrombus) 01/2020 - 12/2016
3	Necrosis 01/2019 - 11/2007
3	Aneurysm (Aneurysms) 10/2016 - 09/2008
3	Arthrogryposis 01/2015 - 05/2007
3	Immune System Diseases (Immune Disorders) 06/2013 - 03/2007
2	Dementia (Dementias) 05/2024 - 01/2023
2	Genetic Predisposition to Disease (Genetic Predisposition) 11/2023 - 02/2016
2	Type 2 Diabetes Mellitus (MODY) 11/2023 - 01/2021
2	Glioma (Gliomas) 10/2023 - 01/2020
2	Adenocarcinoma 07/2023 - 11/2005
2	Overweight 10/2021 - 05/2009
2	COVID-19 01/2021 - 01/2020
2	Myocardial Infarction 12/2020 - 01/2019
2	Lung Neoplasms (Lung Cancer) 12/2020 - 08/2008
2	Major Depressive Disorder (Major Depressive Disorders) 01/2020 - 01/2017
2	Carcinogenesis 01/2020 - 03/2016
2	Pneumonia (Pneumonitis) 01/2020 - 01/2020
2	Mental Disorders (Mental Disorder) 01/2020 - 07/2014
2	Coronary Disease (Coronary Heart Disease) 01/2020 - 07/2009
2	Infections 01/2020 - 06/2016
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 10/2014
2	Abdominal Obesity 01/2018 - 07/2014
2	Rupture 09/2017 - 12/2016
2	Hypoxia (Hypoxemia) 11/2016 - 03/2013
2	Weight Gain 07/2016 - 03/2013
2	Weight Loss (Weight Reduction) 04/2016 - 11/2014
2	Contact Dermatitis (Eczema, Contact) 11/2014 - 03/2007
2	Osteosarcoma (Osteogenic Sarcoma) 01/2014 - 04/2011
2	Pain (Aches) 12/2013 - 04/2013
2	Contracture 09/2013 - 05/2007
2	Ischemia 03/2013 - 03/2009
1	Chronic Renal Insufficiency 05/2024
1	Peripheral Arterial Disease 05/2024

Drug/Important Bio-Agent (IBA)

14	Particulate MatterIBA 04/2024 - 01/2019
8	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 05/2009
8	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2016
8	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2004
7	LipidsIBA 05/2024 - 02/2016
7	SaltsIBA 05/2024 - 07/2015
7	Long Noncoding RNAIBA 01/2023 - 01/2020
6	Competitive Endogenous RNAIBA 10/2023 - 01/2020
5	Messenger RNA (mRNA)IBA 10/2023 - 08/2008
5	CytokinesIBA 03/2022 - 11/2014
5	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 11/2015 - 08/2012
4	Triglycerides (Triacylglycerol)IBA 04/2024 - 01/2018
4	Blood Glucose (Blood Sugar)IBA 10/2023 - 06/2017
4	TeaIBA 03/2022 - 04/2014
4	HDL CholesterolIBA 01/2021 - 10/2015
4	MicroRNAs (MicroRNA)IBA 01/2021 - 03/2016
4	EnzymesIBA 10/2020 - 04/2016
3	RNA (Ribonucleic Acid)IBA 01/2024 - 08/2008
3	LDL CholesterolIBA 01/2023 - 10/2015
3	InflammasomesIBA 03/2020 - 05/2013
3	amsonic acid (DAS)IBA 01/2015 - 05/2007
2	Antihypertensive Agents (Antihypertensives)IBA 05/2024 - 11/2021
2	oxidized low density lipoproteinIBA 01/2023 - 12/2019
2	SodiumIBA 01/2023 - 12/2021
2	Interleukin-10 (Interleukin 10)IBA 01/2021 - 01/2020
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 03/2013
2	ProcalcitoninIBA 01/2021 - 01/2020
2	Antisense RNA (Anti-Sense RNA)IBA 01/2021 - 01/2020
2	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 10/2014
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2020 - 02/2015
2	C-Reactive ProteinIBA 01/2020 - 01/2020
2	PotassiumIBA 12/2017 - 10/2012
2	PolymersIBA 09/2017 - 03/2016
2	ApigeninIBA 01/2017 - 07/2016
2	Protein Isoforms (Isoforms)IBA 11/2016 - 05/2007
2	AntigensIBA 06/2016 - 11/2007
2	Sucrose (Saccharose)IBA 02/2016 - 03/2013
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2016 - 07/2009
2	2- (3,4- dimethoxybenzyl)- 7- (1- (1- hydroxyethyl)- 4- phenylbutyl)- 5- methylimidazo(5,1- f)(1,2,4)triazin- 4 (3H)-oneIBA 02/2015 - 07/2014
2	ferulic acid (sodium ferulate)IBA 02/2015 - 12/2013
2	Annexin A5IBA 01/2014 - 04/2011
2	3'-O-methylastilbinIBA 06/2013 - 03/2007
2	astilbinIBA 06/2013 - 03/2007

Therapy/Procedure

8	Therapeutics 05/2024 - 03/2016
6	Stents 01/2019 - 02/2012
3	Immunotherapy 01/2024 - 01/2022
3	Drug Therapy (Chemotherapy) 09/2021 - 01/2014
2	Punctures 01/2020 - 12/2016
2	Lasers (Laser) 06/2016 - 03/2016